Presenting the latest research findings from the annual meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis.
The final, formatted version of the article will be published soon. Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron neurodegenerative disorder with a median survival of only 3-5 years (1, ...
TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results